Impacts of Social Inequality on Psychedelic Healing with Sean Viña, PhD

Impacts of Social Inequality on Psychedelic Healing with Sean Viña, PhD

In this episode, Dr. Sean M. Viña joins to discuss the ways that social inequality can impact psychedelic healing. Dr. Viña is a sociologist with a PhD from Indiana University whose research focuses on psychedelics and mental health, and social inequality.

In this conversation, Dr. Viña explains that while psychedelics are often framed as transformative treatments, their benefits appear unevenly distributed and frequently constrained by structural factors such as income inequality, education, stigma, caregiving burden, segregation, and social isolation. The discussion highlights how women—particularly single mothers—may experience diminished gains due to caregiving demands and stigmatization of mental illness, while Black and Latino populations show little measurable benefit once socioeconomic inequality is accounted for. Throughout, Dr. Viña emphasizes that outcomes are shaped less by the substances themselves than by the sociocultural environments people return to after treatment, underscoring the importance of community integration and structural supports alongside clinical care.

In this episode, you'll hear:

  • What inspired Dr. Viña to research social inequality and psychedelics
  • How caregiving burden, education, and stigma modulate women's mental health outcomes following psychedelic use
  • Why socioeconomic inequality appears to eliminate measurable benefits for many Black and Latino participants
  • The role of segregation, policing environments, and chronic stress in shaping treatment outcomes
  • Why American Indian populations respond better to psychedelic treatments in rural areas with greater access to nature and their culture
  • How having access to private versus public health insurance can impact psychedelic healing
  • Why focusing only on therapist–patient interactions may miss key determinants of success
  • Implications for designing more equitable psychedelic treatments and research

Quotes:

"Women who are highly educated actually seem to be getting about as much benefit [from psychedelic treatments] as men who are highly educated, but [lack of] education doesn't seem to negatively affect men the same way it affects women. Again, that's the pattern we see in all kinds of other health resources." [9:36]

"One of the studies that we did showed that if it wasn't for education and income differences, there would be a slight benefit [from psychedelics] for black participants in these surveys. But as soon as you accounted for education inequality and income inequality, it was wiped out." [21:40]

"I love the concept of the psychedelic renaissance, but when we start thinking about the statistics of who this is helping, this is a renaissance of less than 1% of people, right? This is a very small group of people who are getting benefits, just like many of the other resources that have come out in the past. … all these resources are probably valuable. They're all helpful. But there needs to be more than just the drug. There needs to be a bigger conversation about this society and the community that people are living in." [36:31]

Dr. Viña's academic articles:

"Medical Sociological and Epidemiological Psychedelics Paradigm", Drug Science Policy and Law, 2025

"A Community Centered Approach to Psychedelics", Discover Mental Health, 2025

"Unequal Healing: Gender, Psychedelics, and the Burden of Care", Women and Therapy, 2026

"Psychedelics and Mental Health Treatment Seeking Among Asians and Hawaiians", Psychoactives, 2025

"American Indian areas and psychedelics: A test of the minorities' diminished psychedelic returns", Journal of Rural Mental Health, 2025

"Religious Social Integration, Psychedelics, and Psychological Distress", Journal of Psychoactive Drugs, 2024

"Stigma, Psychedelic Use, and the Risk of Reduced Formal Mental Health Care", Stigma and Health, 2024

With Amanda L. Stephens: "Minorities' Diminished Psychedelic Returns." Drug Science, Policy and Law, 2023

Links:

Dr. Viña on LinkedIn

Dr. Viña on Researchgate

Previous episode: Psychedelics and Religion with Hunt Priest, MDiv

Psychedelic Medicine Association

Porangui

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(209)

Why Psychedelics Don't Always Change Us with Nigel Denning, MA, MPsych

Why Psychedelics Don't Always Change Us with Nigel Denning, MA, MPsych

In this episode of the Psychedelic Medicine Podcast, Nigel Denning, MA, MPsych, joins to discuss the reasons profound psychedelic experiences don't always lead to lasting change. Nigel is a Counsellin...

9 Sep 35min

Who Is a Good Candidate for Ibogaine? with Fernando Rivas, MD

Who Is a Good Candidate for Ibogaine? with Fernando Rivas, MD

In this episode of the Psychedelic Medicine Podcast, Fernando Rivas, MD, joins to unpack the safety and screening considerations for ibogaine therapy. Dr. Rivas is an emergency physician with over 15 ...

27 Aug 39min

Encore Episode: Psychedelics and Breathwork with Kyle Buller

Encore Episode: Psychedelics and Breathwork with Kyle Buller

This encore episode of the Psychdelic Medicine Podcast features a conversation with Kyle Buller on psychedelics and breathwork. Kyle is co-founder and host of the Psychedelics Today podcast and he has...

13 Aug 43min

Psychedelics and Psychosis with Alexander Lebedev, MD, PhD

Psychedelics and Psychosis with Alexander Lebedev, MD, PhD

In this episode of the Psychedelic Medicine Podcast, Alexander Lebedev, MD, PhD joins to discuss psychedelic medicine and psychosis. Dr. Lebedev is a physician-scientist, medical AI engineer, and entr...

30 Jul 46min

Psychedelics and GLP-1s with Arsalan Azam, MD

Psychedelics and GLP-1s with Arsalan Azam, MD

In this episode of the Psychedelic Medicine Podcast, Arsalan Azam, MD joins to unpack the intersection between psychedelics and GLP-1s. Dr. Azam, founder of Daydream MD, completed his residency in Eme...

14 Jul 36min

Psilocybin vs. Ketamine with Dori Lewis, LPC

Psilocybin vs. Ketamine with Dori Lewis, LPC

In this episode of the Psychedelic Medicine Podcast, Dori Lewis, MA, MEd, LPC-S returns to discuss the differences between psilocybin and ketamine. Dori is the Clinical Director of Elemental Psychedel...

2 Jul 43min

Choosing the Right Ketamine Clinic for You with Katie Fassbinder, MD

Choosing the Right Ketamine Clinic for You with Katie Fassbinder, MD

In this episode of the Psychedelic Medicine Podcast, Katie Fassbinder, MD joins to explore how to choose the right ketamine clinic. Dr. Fassbinder is the Faculty Medical Lead for ketamine-assisted psy...

11 Jun 50min

The Future of Psychedelic Medicine with Ismail Lourido Ali, JD

The Future of Psychedelic Medicine with Ismail Lourido Ali, JD

In the 200th episode of the Psychedelic Medicine Podcast, Ismail Lourido Ali, JD joins to discuss the future of psychedelic medicine. Ismail serves as MAPS Co-Executive Director and has been actively ...

28 Mai 52min

Populært innen Helse

fastlegen
rss-gukild-johaug
psykodrama
hvordan-har-du-det-mann
leger-om-livet
relasjonspodden-med-dora-thorhallsdottir-kjersti-idem
rss-skravla-gar
foreldreradet
g-punktet
rss-dagen-for-dagen
hjernesterk
rss-lopedrommen
morten-ramm-lar-kakla-ga-til-du-sovner
klimaks
treningsprat
bak-fasaden-en-reise-i-livet-med-sykepleier-ine
rss-loping-for-nybegynnere
rss-kunsten-a-leve
kjed-deg-i-sovn-verdens-kjedeligste-podcast
helsetipspodden